Literature DB >> 27738878

Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study.

Federico Sista1,2, Valentina Abruzzese3, Marco Clementi3, Sergio Carandina4, Gianfranco Amicucci3.   

Abstract

BACKGROUND: The correlation between resected gastric volume (RGV) and neuro-humoral changes (ghrelin and GLP-1) after laparoscopic sleeve gastrectomy (LSG) and their effects on type 2 diabetes mellitus (T2DM) has been evaluated. MATERIALS: Ninety-eight patients were divided in two groups: RGV <1200 mL (group A: 53 pts) and RGV >1200 mL (group B: 45 pts). Insulin secretion (insulin area under the curve (AUC)), insulinogenic index (IGI) and insulin-resistance (homeostasis model assessment, HOMAIR) were assessed before and after surgery (at the 3rd day and 6, 12 and 24 months after LSG) using the oral glucose tolerance test (OGTT). At the same time, ghrelin and GLP-1 levels were determined.
RESULTS: A significant difference in T2DM resolution rate was observed after 6, 12 and 24 months in favour of RGV >1200 mL. Group B performed better than group A at the 3rd day and at the 6th, 12th and 24th months with regard to AUC, IGI and HOMAIR. In both groups, OGTT resulted in decreased ghrelin values and a significant increase in GLP-1 values for group B at the 3rd day and at the 6th and 12th months with no difference at the 24th month.
CONCLUSION: Ghrelin and GLP-1 changes play a role in the regulation of glucose metabolism during the 1st year after LSG. RGV influences ghrelin and GLP-1 plasma levels after LSG, with a significant improvement in the T2DM control.

Entities:  

Keywords:  Bariatric surgery; Diabetes mellitus type 2; Obesity; Sleeve gastrectomy; Volume resected

Mesh:

Substances:

Year:  2016        PMID: 27738878     DOI: 10.1007/s11605-016-3292-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  31 in total

1.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

Authors:  Fabiola Romero; Joana Nicolau; Lílliam Flores; Roser Casamitjana; Ainitze Ibarzabal; Antonio Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

3.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 4.  Surgery in the treatment of type 2 diabetes mellitus.

Authors:  A Maleckas; L Venclauskas; V Wallenius; H Lönroth; L Fändriks
Journal:  Scand J Surg       Date:  2015-01-26       Impact factor: 2.360

5.  Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.

Authors:  Sarah Evans; Zehra Pamuklar; Jonathan Rosko; Patrick Mahaney; Ning Jiang; Chan Park; Alfonso Torquati
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

6.  Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.

Authors:  David Nocca; Fabre Guillaume; Patrick Noel; Marie Christine Picot; Rajesh Aggarwal; Moez El Kamel; Roxanne Schaub; Charles de Seguin de Hons; Eric Renard; Jean Michel Fabre
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

7.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

Review 8.  The effects of bougie caliber on leaks and excess weight loss following laparoscopic sleeve gastrectomy. Is there an ideal bougie size?

Authors:  Jonathan B Yuval; Yoav Mintz; Matan J Cohen; Avraham I Rivkind; Ram Elazary
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

9.  Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction.

Authors:  S Yip; M Signal; G Smith; G Beban; M Booth; R Babor; J G Chase; R Murphy
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

Review 10.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

View more
  10 in total

1.  Effect of Laparoscopic Sleeve Gastrectomy on Type 2 Diabetes Mellitus in Patients with Body Mass Index less than 30 kg/m2.

Authors:  Lun Wang; Jinfa Wang; Tao Jiang
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

2.  Glucose variability and predicted cardiovascular risk after gastrectomy.

Authors:  Jun Shibamoto; Takeshi Kubota; Takuma Ohashi; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Surg Today       Date:  2022-03-31       Impact factor: 2.549

3.  Pancreas is a preeminent source of ghrelin after sleeve gastrectomy in Wistar rats.

Authors:  Alonso Camacho-Ramírez; María Ángeles Mayo-Ossorio; José Manuel Pacheco-García; David Almorza-Gomar; Antonio Ribelles-García; Ana Belmonte-Núñez; J Arturo Prada-Oliveira; Gonzalo M Pérez-Arana
Journal:  Histol Histopathol       Date:  2020-01-17       Impact factor: 2.303

4.  Residual Gastric Volume Relationship and Weight Loss After Laparoscopic Sleeve Gastrectomy.

Authors:  Sami Doğan; Attila Önmez; Mehmet Fuat Çetin; İsmet Özaydın; Mevlüt Pehlivan
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

5.  High Resected Gastric Volume and poorly controlled DM2 in laparoscopic sleeve gastrectomy.

Authors:  Federico Sista; Valentina Abruzzese; Stefano Guadagni; Sergio Carandina; Marco Clementi
Journal:  Ann Med Surg (Lond)       Date:  2018-11-03

6.  Which is the correlation between carcinoid tumor and Laparoscopic Sleeve Gastrectomy? A case series and literature review.

Authors:  Federico Sista; Valentina Abruzzese; Sergio Carandina; Andrea Salvatorelli; Marino Di Furia; Gianluca Cipolloni; Vincenzo Vicentini; Stefano Guadagni; Marco Clementi
Journal:  Ann Med Surg (Lond)       Date:  2018-09-19

Review 7.  Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery.

Authors:  Belén Pérez-Pevida; Javier Escalada; Alexander D Miras; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-19       Impact factor: 5.555

Review 8.  Bariatric Surgery and Type 1 Diabetes: Unanswered Questions.

Authors:  Emmanouil Korakas; Aikaterini Kountouri; Athanasios Raptis; Alexander Kokkinos; Vaia Lambadiari
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

9.  The rapid effects of sleeve gastrectomy on glucose homeostasis and resolution of diabetes mellitus.

Authors:  Emre Bozkurt; Cemal Kaya; Sinan Ömeroğlu; Onur Güven; Mehmet Mihmanlı
Journal:  Endocrinol Diabetes Metab       Date:  2020-08-30

Review 10.  Endoscopic intragastric balloon: a gimmick or a viable option for obesity?

Authors:  Katja Susanne Claudia Gollisch; Dirk Raddatz
Journal:  Ann Transl Med       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.